Copy number variation of KIR genes influences HIV-1 control

PLoS Biology

Volumn 9, Issue 11, 2011, Pages

  Pelak, Kimberly ^a   Need, Anna C ^a   Fellay, Jacques ^a,b   Shianna, Kevin V ^a   Feng, Sheng ^a   Urban, Thomas J ^a   Ge, Dongliang ^a   de Luca, Andrea ^c,d   Martinez Picado, Javier ^e,f   Wolinsky, Steven M ^g   Martinson, Jeremy J ^h   Jamieson, Beth D ⁱ   Bream, Jay H ^j   Martin, Maureen P ^k   Borrow, Persephone ^l   Letvin, Norman L ^m   McMichael, Andrew J ⁿ   Haynes, Barton F ^a   Telenti, Amalio ^o   Carrington, Mary ^i,p   Goldstein, David B ^a   Alter, Galit ^p   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EPFL   (Switzerland)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY HOSPITAL OF SIENA   (Italy)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^k SAIC FREDERICK INC   (United States)

^l UNIVERSITY OF OXFORD   (United Kingdom)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^o UNIVERSITY OF LAUSANNE   (Switzerland)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIR GENE; KIR3DL1 GENE; KIR3DS1 GENE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; BIOLOGICAL MODEL; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

COHORT STUDIES; DNA COPY NUMBER VARIATIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; RECEPTORS, KIR; VIRAL LOAD; VIRUS REPLICATION;

EID: 82455192837     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001208     Document Type: Article

References (47)

1. Bashirova A. A, Martin M. P, McVicar D. W, Carrington M, (2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7: 277-300.
2. Uhrberg M, Valiante N. M, Shum B. P, Shilling H. G, Lienert-Weidenbach K, et al. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763.
3. Carrington M, Martin M. P, van Bergen J, (2008) KIR-HLA intercourse in HIV disease. Trends Microbiol 16: 620-627.
4. Martin M. P, Bashirova A, Traherne J, Trowsdale J, Carrington M, (2003) Cutting Edge: expansion of the KIR locus by unequal crossing over. J Immunol 171: 2192-1295.
5. Williams F, Maxwell L. D, Halfpenny I. A, Meenagh A, Sleator C, et al. (2003) Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. Hum Immunol 64: 729-732.
6. Qi Y, Martin M. P, Gao X, Jacobson L, Goedert J. J, et al. (2006) KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2: e79 doi:10.1371/journal.ppat.0020079.
7. Martin M. P, Gao X, Lee J. H, Nelson G. W, Detels R, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434.
8. Alter G, Martin M. P, Teigen N, Carr W. H, Suscovich T. J, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 404: 3027-3036.
9. Long B. R, Ndhlovu L. C, Oksenberg J. R, Lanier L. L, Hecht F. M, et al. (2008) Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J Virol 82: 4785-4792.
10. Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, et al. (2005) Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 6: 683-690.
11. Barbour J. D, Sriram U, Caillier S. J, Levy J. A, Hecht F. M, et al. (2007) Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog 3: e43 doi:10.1371/journal.ppat.0030043.
12. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie C. M, et al. (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
13. Martin M. P, Qi Y, Gao X, Yamada E, Martin J. N, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740.
14. Kim S, Poursine-Laurent J, Truscott S. M, Lybarger L, Song Y. J, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
15. Fernandez N. C, Treiner E, Vance R. E, Jamieson A. M, Lemieux S, et al. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
16. Anfossi N, André P, Guia S, Falk C. S, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342.
17. Altfeld M, Goulder P, (2007) 'Unleashed' natural killers hinder HIV. Nat Genet 39: 708-710.
18. Li H, Pascal V, Martin M. P, Carrington M, Anderson S. K, (2008) Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 4: e10000254 doi:10.1371/journal.pgen.1000254.
19. Pascal V, Yamada E, Martin M. P, Alter G, Altfeld M, et al. (2007) Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 179: 1625-1633.
20. Gardiner C. M, Guethlein L. A, Shilling H. G, Pando M, Carr W. H, et al. (2001) Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166: 2992-3001.
21. Norman P. J, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, et al. (2007) Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 39: 1092-1099.
22. Fellay J, Shianna K. V, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
23. Wang K, Li M, Hadley D, Liu R, Glessner J, et al. (2007) PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17: 1665-1674.
24. Price A. L, Patterson N. J, Plenge R. M, Weinblatt M. E, Shadick N. A, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
25. Single R. M, Martin M. P, Meyer D, Gao X, Carrington M, (2008) Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics 60: 711-725.
26. Cella M, Longo A, Ferrara G. B, Strominger J. L, Colonna M, (1994) NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180: 1235-1242.
27. Gumperz J. E, Barber L. D, Valiante N. M, Percival L, Phillips J. H, et al. (1997) Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 158: 5237-5241.
28. Gillespie G. M, Bashirova A, Dong T, McVicar D. W, Rowland-Jones S. L, et al. (2007) Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. AIDS Res Hum Retroviruses 23: 451-455.
29. Carr W. H, Rosen D. B, Arase H, Nixon D. F, Michaelsson J, et al. (2007) KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178: 647-651.
30. O'Connor G. M, Guinan K. J, Cunningham R. T, Middleton D, Parham P, et al. (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178: 235-241.
31. Pando M. J, Gardiner C. M, Gleimer M, McQueen K. L, Parham P, (2003) The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171: 6640-6649.
32. Kiepiela P, Leslie A. J, Honeyborne I, Ramduth D, Thobakgale C, et al. (2004) Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
33. Gao X, Bashirova A, Iversen A. K, Phair J, Goedert J. J, et al. (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11: 1290-1292.
34. Carrington M, O'Brien S. J, (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551.
35. Gao X, Nelson G. W, Karacki P, Martin M. P, Phair J, et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344: 1668-1675.
36. Hanke T, Takizawa H, Raulet D. H, (2001) MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol 31: 3370-3379.
37. Held W, Dorfman J. R, Wu M. F, Raulet D. H, (1996) Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol 26: 2286-2292.
38. Alter G, Rihn S, Walter K, Nolting A, Martin M, et al. (2009) HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol 83: 6798-6805.
39. Pascal V, Yamada E, Martin M. P, Alter G, Altfeld M, et al. (2007) Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 179: 1625-1633.
40. Fellay J, Ge D, Shianna K. V, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791 doi:10.1371/journal.pgen.1000791.
41. Cohen G. B, Gandhi R. T, Davis D. M, Mandelboim O, Chen B. K, et al. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity Jun;10 (6): 661-671.
42. Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, et al. (2009) HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog Oct;5 (10): e1000613 doi:10.1371/journal.ppat.1000613.
43. Richard J, Sindhu S, Pham T. N, Belzile J. P, Cohen E. A, (2010) HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood Feb 18;115 (7): 1354-1363.
44. Shah A. H, Sowrirajan B, Davis Z. B, Ward J. P, Campbell E. M, et al. (2010) Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe Nov 18;8 (5): 397-409.
45. Kim S, Sunwoo J. B, Yang L, Choi T, Song Y. J, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A Feb 26;105 (8): 3053-3058.
46. Sun J. C, Beilke J. N, Lainer L. L, (2009) Adaptive immune features of natural killer cells. Nature 457: 557-561.
47. Martin M. P, Carrington M, (2008) KIR locus polymorphisms: genotyping and disease association analysis. Methods Mol Biol 415: 49-64.